Greater Occipital Nerve Block for Migraine Prophylaxis

Closed

The purpose of this study is to determine whether greater occipital nerve block injection reduces the frequency of migraine headaches.

Inclusion Criteria:

- Age 18-75 years.

- ICHD-II episodic or chronic migraine.

- At least 1 attack per week.

Exclusion Criteria:

- Pregnant or lactating.

- Continuous headache.

- Maintenance opioid medication.

- Started migraine prophylactic medication within the past 2 months.

- Hypersensitivity to study ingredients.

- Investigational medication within 90 days of screening.

- Injection site infection at injection visit.

- Systemic infection at injection visit.

- Cranial bone defect.

- Chronic cluster headache, new daily persistent headache, hemicrania continua, or chronic tension type headache.

Last updated: 03/05/2013

NCT ID: NCT00915473

IRB Number:08-008203

Clinical Trials